Abstract
Mesenchymal stem cells (MSCs) have attracted a great deal of interest in the field of regenerative medicine because of their ability to differentiate into mesodermal derivatives and even other germ layers. The main requirement for better differentiation of MSCs into desired cell lineage is relied on pure population of these cells. During the past years, significant progresses have been developed for the identification of MSCs by introducing new markers or different combination of markers. Currently, direct in vitro differentiation protocols using standard media supplemented with specific growth factors generating osteoblast, insulin producing and neuron cells from MSCs show some key characteristic in in vivo counterparts. However, these efforts should be continued to achieve high amount of fully differentiated cells which have high capacity to be used in cell based therapies and drug screening. This review focuses on common culture based differentiation strategies used for osteoblast, insulin producing cells and neural cells generation from MSCs highlighting important findings and trends in this exciting area.
Keywords: Mesenchymal stem cells, directed differentiation, insulin producing cells and neural cells, neural cells, osteoblast, induced pluripotent stem cells.
[1]
Heo JS, Choi Y, Kim H-S, Kim HO. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med 2016; 37(1): 115-25.
[2]
Dickinson SC, Sutton CA, Brady K, et al. The Wnt5a receptor, receptor tyrosine kinase‐like orphan receptor 2, is a predictive cell surface marker of human mesenchymal stem cells with an enhanced capacity for chondrogenic differentiation. Stem Cells 2017; 35(11): 2280-91.
[3]
Demir AK, Elçin AE, Elçin YM. Osteogenic differentiation of encapsulated rat mesenchymal stem cells inside a rotating microgravity bioreactor: In vitro and in vivo evaluation. Cytotechnology 2018; 1-14.
[4]
Shi C, Zhang M, Tong M, et al. miR-148a is associated with obesity and modulates adipocyte differentiation of mesenchymal stem cells through Wnt signaling. Sci Rep 2015; 5: 9930.
[5]
Takeda YS, Xu Q. Neuronal differentiation of human mesenchymal stem cells using exosomes derived from differentiating neuronal cells. PLoS One 2015; 10(8)e0135111
[6]
Sharma D, Hamlet SM, Petcu EB, Ivanovski S. The effect of bisphosphonates on the endothelial differentiation of mesenchymal stem cells. Sci Rep 2016; 6: 20580.
[7]
Bai C, Gao Y, Li Q, et al. Differentiation of chicken umbilical cord mesenchymal stem cells into beta-like pancreatic islet cells. Artif Cells Nanomed Biotechnol 2015; 43(2): 106-11.
[8]
Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 2016; 39(7): 1230-40.
[9]
Kim HJ, Park J-S. Usage of human mesenchymal stem cells in cell-based therapy: Advantages and disadvantages. Dev Reprod 2017; 21(1): 1.
[10]
Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods 2016; 99: 62-8.
[11]
Tavassoli M, Crosby WH. Transplantation of marrow to extramedullary sites. Science 1968; 161(3836): 54-6.
[12]
Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17(4): 331-40.
[14]
Horwitz E, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7(5): 393-5.
[15]
Chaput B, Bertheuil N, Escubes M, et al. Mechanically isolated stromal vascular fraction provides a valid and useful collagenase-free alternative technique: A comparative study. Plast Reconstr Surg 2016; 138(4): 807-19.
[16]
Bellei B, Migliano E, Tedesco M, Caputo S, Picardo M. Maximizing non-enzymatic methods for harvesting adipose-derived stem from lipoaspirate: technical considerations and clinical implications for regenerative surgery. Sci Rep 2017; 7(1): 10015.
[17]
Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells-current trends and future prospective. Biosci Rep 2015; 35(2)e00191
[18]
da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119(11): 2204-13.
[19]
Huang S, Xu L, Sun Y, Wu T, Wang K, Li G. An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. J Orthop Translat 2015; 3(1): 26-33.
[20]
Caroti CM, Ahn H, Salazar HF, et al. A novel technique for accelerated culture of murine mesenchymal stem cells that allows for sustained multipotency. Sci Rep 2017; 7(1): 13334.
[21]
Tevlin R, McArdle A, Brett E, et al. A novel method of human adipose-derived stem cell isolation with resultant increased cell yield. Plast Reconstr Surg 2016; 138(6): 983e-96e.
[22]
Zhang B, Zhang J, Shi H, et al. A novel method to isolate mesenchymal stem cells from mouse umbilical cord. Mol Med Rep 2018; 17(1): 861-9.
[23]
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(12): 4279-95.
[24]
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-7.
[25]
Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW. Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol Cell Biol 2013; 91(1): 32-9.
[26]
Chang Y-J, Tseng C-P, Hsu L-F, Hsieh T-B, Hwang S-M. Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int 2006; 30(6): 495-9.
[27]
Battula VL, Treml S, Bareiss PM, et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 2009; 94(2): 173-84.
[28]
Ghaneialvar H, Soltani L, Rahmani HR, Lotfi AS, Soleimani M. Characterization and classification of mesenchymal stem cells in several species using surface markers for cell therapy purposes. Indian J Clin Biochem 2018; 33(1): 46-52.
[29]
Menicanin D, Bartold PM, Zannettino AC, Gronthos S. Genomic profiling of mesenchymal stem cells. Stem Cell Rev 2009; 5(1): 36-50.
[30]
Ogurtsova K, da Rocha Fernandes J, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50.
[31]
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292(5520): 1389-94.
[32]
Liu H, Guo D, Ruzi A, et al. Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells. PLoS One 2017; 12(6)e0179353
[33]
Timper K, Seboek D, Eberhardt M, et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006; 341(4): 1135-40.
[34]
Jafarian A, Taghikani M, Abroun S, et al. The generation of insulin producing cells from human mesenchymal stem cells by MiR-375 and anti-MiR-9. PLoS One 2015; 10(6)e0128650
[36]
Yang S-F, Xue W-J, Duan Y-F, Eds. et al.editors. Nicotinamide facilitates
mesenchymal stem cell differentiation into insulin-producing
cells and homing to pancreas in diabetic mice. Transplant Proc; Elsevier 2015.
[37]
Chen L-B, Jiang X-B, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 2004; 10(20): 3016.
[38]
Tang D-Q, Cao L-Z, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004; 53(7): 1721-32.
[39]
El-Asfar RK, Kamal MM. EL-Razek RSA, Ebtehal E-D, El-Mesallamy HO. Obestatin can potentially differentiate Wharton’s jelly mesenchymal stem cells into insulin-producing cells. Cell Tissue Res 2018; 372(1): 91-8.
[40]
Hu Y-h, Wu D-q, Gao F, Li G-d, Zhang X-c. Notch signaling: A novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro. Chin Med J (Engl) 2010; 123(5): 606-14.
[41]
Dayer D, Tabar MH, Moghimipour E, et al. Sonic hedgehog pathway suppression and reactivation accelerates differentiation of rat adipose-derived mesenchymal stromal cells toward insulin-producing cells. Cytotherapy 2017; 19(8): 937-46.
[42]
Wang H, Ren Y, Hu X, et al. Effect of Wnt signaling on the differentiation of islet β-cells from adipose-derived stem cells. BioMed Res Int 2017; 20172501578
[43]
Karnieli O, Izhar‐Prato Y, Bulvik S, Efrat S. Generation of insulin‐producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007; 25(11): 2837-44.
[44]
Xu L, Xu C, Zhou S, et al. PAX4 promotes PDX1-induced differentiation of mesenchymal stem cells into insulin-secreting cells. Am J Transl Res 2017; 9(3): 874.
[45]
Enderami SE, Soleimani M, Mortazavi Y, Nadri S, Salimi A. Generation of insulin‐producing cells from human adipose‐derived mesenchymal stem cells on PVA scaffold by optimized differentiation protocol. J Cell Physiol 2018; 233(5): 4327-37.
[46]
Seyedi F, Farsinejad A, Nematollahi-Mahani SN. Fibrin scaffold enhances function of insulin producing cells differentiated from human umbilical cord matrix-derived stem cells. Tissue Cell 2017; 49(2): 227-32.
[47]
Muir JM, Ye C, Bhandari M, Adachi JD, Thabane L. The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: A retrospective analysis from the Canadian multicentre osteoporosis study. Biotechnol Appl Biochem 2013; 14(1): 253.
[48]
Papachroni KK, Karatzas DN, Papavassiliou KA, Basdra EK, Papavassiliou AG. Mechanotransduction in osteoblast regulation and bone disease. Trends Mol Med 2009; 15(5): 208-16.
[49]
Tang D, Ju C, Liu Y, Xu F, Wang Z, Wang D. Therapeutic effect of icariin combined with stem cells on postmenopausal osteoporosis in rats. J Bone Miner Metab 2018; 36(2): 180-8.
[50]
Pinkerton JV, Thomas S, Dalkin AC. Osteoporosis treatment and prevention for postmenopausal women: current and future therapeutic options. Clin Obstet Gynecol 2013; 56(4): 711-21.
[51]
Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y. Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit 2016; 22: 226.
[52]
Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89(5): 755-64.
[53]
Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108(1): 17-29.
[54]
Nishio Y, Dong Y, Paris M, O’Keefe RJ, Schwarz EM, Drissi H. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 2006; 372: 62-70.
[55]
Felber K, Elks PM, Lecca M, Roehl HH. Expression of osterix is regulated by FGF and Wnt/β-catenin signalling during osteoblast differentiation. PLoS One 2015; 10(12)e0144982
[56]
Yang H, Guo Y, Wang D, Yang X, Ha C. Effect of TAK1 on osteogenic differentiation of mesenchymal stem cells by regulating BMP-2 via Wnt/β-catenin and MAPK pathway. Organogenesis 2018; 14(1): 36-45.
[57]
Long F, Chung U-i, Ohba S, McMahon J, Kronenberg HM, McMahon AP. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004; 131(6): 1309-18.
[58]
Otsuki Y, Ii M, Moriwaki K, Okada M, Ueda K, Asahi M. W9 peptide enhanced osteogenic differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun 2018; 495(1): 904-10.
[59]
Bae SJ, Kim HJ, Won HY, Min YK, Hwang ES. Acceleration of osteoblast differentiation by a novel osteogenic compound, DMP-PYT, through activation of both the BMP and Wnt pathways. Sci Rep 2017; 7(1): 8455.
[60]
Yang J-W, Jeong B-C, Park J, Koh J-T. PHF20 positively regulates osteoblast differentiation via increasing the expression and activation of Runx2 with enrichment of H3K4me3. Sci Rep 2017; 7(1): 8060.
[61]
Chudickova M, Bruza P, Zajicova A, et al. Targeted neural differentiation of murine mesenchymal stem cells by a protocol simulating the inflammatory site of neural injury. J Tissue Eng Regen Med 2017; 11(5): 1588-97.
[62]
Isern J, García-García A, Martín AM, et al. The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function. eLife 2014; 3e03696
[63]
Yu Q, Liu L, Duan Y, et al. Wnt/β-catenin signaling regulates neuronal differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 2013; 439(2): 297-302.
[64]
Su C-H, Hung K-Y, Hung S-C, Tarn W-Y. RBM4 regulates neuronal
differentiation of mesenchymal stem cells by modulating alternative
splicing of pyruvate kinase M Mol Cell Biol 2016. MCB.00466-16.
[65]
Shi Y, Hu Y, Lv C, Tu G. Effects of reactive oxygen species on differentiation of bone marrow mesenchymal stem cells. Ann Transplant 2016; 21: 695-700.
[66]
Dong B-T, Tu G-J, Han Y-X, Chen Y. Lithium enhanced cell proliferation and differentiation of mesenchymal stem cells to neural cells in rat spinal cord. Int J Clin Exp Pathol 2015; 8(3): 2473.
[67]
Fathi E, Farahzadi R, Charoudeh HN. L-carnitine contributes to enhancement of neurogenesis from mesenchymal stem cells through Wnt/β-catenin and PKA pathway. Exp Biol Med 2017; 242(5): 482-6.
[68]
Stapleton D, Mitchelhill KI, Gao G, et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 1996; 271(2): 611-4.
[69]
Dasgupta B, Milbrandt J. AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev Cell 2009; 16(2): 256-70.
[70]
Ahn MJ, Cho GW. Metformin promotes neuronal differentiation and neurite outgrowth through AMPK activation in human bone marrow–mesenchymal stem cells. Biotechnol Appl Biochem 2017; 64(6): 836-42.
[71]
Amirkhani MA, Mohseni R, Soleimani M, Shoae-Hassani A, Nilforoushzadeh MA. A rapid sonication based method for preparation of stromal vascular fraction and mesenchymal stem cells from fat tissue. Bioimpacts 2016; 6(2): 99.
[72]
Jia Z, Liang Y, Xu X, et al. Isolation and characterization of human mesenchymal stem cells derived from synovial fluid by magnetic‐activated cell sorting (MACS). Cell Biol Int 2018; 42(3): 262-71.
[73]
De Francesco F, Mannucci S, Conti G, Dai Prè E, Sbarbati A, Riccio M. A non-enzymatic method to obtain a fat tissue derivative highly enriched in adipose stem cells (ascs) from human lipoaspirates: Preliminary results. Int J Mol Sci 2018; 19(7): 2061.
[74]
Raposio E, Caruana G, Bonomini S, Libondi G. A novel and effective strategy for the isolation of adipose-derived stem cells: minimally manipulated adipose-derived stem cells for more rapid and safe stem cell therapy. Plast Reconstr Surg 2014; 133(6): 1406-9.
[75]
Hasehira K, Hirabayashi J, Tateno H. Structural and quantitative evidence of α2-6-sialylated N-glycans as markers of the differentiation potential of human mesenchymal stem cells. Glycoconj J 2017; 34(6): 797-806.
[76]
Sun Y, Chen L, Hou X-G, et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) 2007; 120(9): 771.
[77]
Kim S-Y, Kim Y-R, Park W-J, et al. Characterisation of insulin-producing cells differentiated from tonsil derived mesenchymal stem cells. Differentiation 2015; 90(1-3): 27-39.
[78]
Xin Y, Jiang X, Wang Y, et al. Insulin-producing cells differentiated from human bone marrow mesenchymal stem cells in vitro ameliorate streptozotocin-induced diabetic hyperglycemia. PLoS One 2016; 11(1)e0145838
[79]
Bai C, Gao Y, Li X, et al. MicroRNAs can effectively induce formation of insulin‐producing cells from mesenchymal stem cells. J Tissue Eng Regen Med 2017; 11(12): 3457-68.
[80]
Nadri S, Barati G, Mostafavi H, Esmaeilzadeh A, Enderami SE. Differentiation of conjunctiva mesenchymal stem cells into secreting islet beta cells on plasma treated electrospun nanofibrous scaffold. Artif Cells Nanomed Biotechnol 2018; 46(sup1): 178-87.
[81]
Kähkönen T, Ivaska K, Jian M, Büki K, Väänänen H, Härkönen P. Role of fibroblast growth factor receptors (FGFR) and FGFR like-1 (FGFRL1) in mesenchymal stromal cell differentiation to osteoblasts and adipocytes. Mol Cell Endocrinol 2018; 461: 194-204.
[82]
Abdallah BM, Alzahrani AM, Kassem M. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway. Bone 2018; 110: 221-9.
[83]
Han HS, Ju F, Geng S. In vivo and in vitro effects of PTH1‐34 on osteogenic and adipogenic differentiation of human bone marrow‐derived mesenchymal stem cells through regulating microRNA‐155. J Cell Biochem 2018; 119(4): 3220-35.
[84]
He X, He J, Shi Y, et al. Nicotinamide phosphoribosyltransferase (Nampt) may serve as the marker for osteoblast differentiation of bone marrow-derived mesenchymal stem cells. Exp Cell Res 2017; 352(1): 45-52.
Article Metrics
45
3